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Two  types of immunofluorescence tests are being applied to studies of Burkitt's 
lymphoma. In one of these (1,  2),  ceils from fresh biopsies or from certain lines of 
tumor cultures are stained vitally by the indirect technique,  using sera of patients 
with this malignancy for the primary reaction. This test reveals surface antigens of 
tumor-derived cells which are not present in the membranes of fresh bone marrow 
cells of autochthonous or other Burkitt tumor patients. It will be referred to as mem- 
brane immunofluorescence or MIF test. In the other test (3),  acetone-fixed smears 
of cultured Burkitt tumor cells are stained by the indirect method with various human 
sera or by the  direct technique  with  fluorescein isothiocyanate-conjugated human 
7-globulins. This  test  detects  the  fraction  of  cells in  various lines which  produce 
Epstein-Barr or EB  virus particles and  therefore will be referred to  as EBV  test. 
The EBV-specificity of the reactions obtained is attested by the facts  that (a) there 
exists a  good correlation between the numbers of cells in individual lines which yield 
immunofluorescence and cells revealing herpes group virus particles on electron mi- 
croscopic examination  (3-5);  (b)  manipulations of  the  cultures  which  increase  or 
decrease the numbers of  fluorescent cells lead to similar changes in the numbers of 
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cells which harbor  virus particles (4-6); (c) sera which elicit immunofluorescence con- 
tain antibodies to the EB virion  as evident from antibody coating and agglutination 
of partially purified virus particles  (7,  8);  (d)  radioautography  1-2 days  after  a  3H- 
thymidine pulse has shown  (9)  that  the majority of fluorescent cells contain isotope 
in the cytoplasma  (viral DNA) whereas in nonfluorescent cells the label, if present, 
is restricted to the nucleus (cellular DNA); and (e)  examination of individual fluores- 
cent cells has revealed that they contain numerous virus particles (9,  10). 
It was  of interest  to determine  whether  and  to  what  extent  the  membrane 
immunofluorescence  reaction  depends  upon  the  presence  of  EBV  in  blastoid 
cell  populations.  In  the  first  series  of  experiments,  attempts  were  made  to 
correlate  the  MIF  activities  of  various  cell populations,  as  elicited  with  the 
aid of a  standard  serum,  with the extents of the EBV infection. The results are 
presented  below. 
Materials and Methods 
Cells.--The preparation of cell suspensions  from Burkitt tumor biopsies and the establish- 
ment and maintenance of the cultures employed in these studies have been described (1, 2, 11). 
Membrane Immunofluorescence Test.--The  techniques  employed  have  been  reported  in 
detail (1, 2, 12). It was known that certain sera,  and particularly those derived from Burkitt 
patients  whose  tumors  went  into  long-lasting remission Mter  chemotherapy,  gave a  high 
incidence of positive reactions with cells from Burkitt lymphoma biopsies,  but not with cells 
from fresh bone marrow biopsies of Burkitt patients, allogeneic lymph node ceils, or allogeneic 
leukemic cells of various kinds  (13).  For this reason,  one particular serum was selected as 
standard and used exclusively in the present studies. This serum was derived from the donor 
Muttm (Kenya Cancer Council ~K.C.C.] No. 454),  a 5 yr-old boy with histologically confirmed 
Burkitt lymphoma who has been in maintained remission after chemotherapy for more than 
3 yr. This serum, which has been studied in great detail, lacked detectable isoantibodies, as 
judged by lymphocytotoxicity, leukoagglutination, and membrane immunofluorescence with 
bone marrow cells from donors of known leukocyte antigen groups (2). It reacted well against 
13 of 16 Burkitt biopsies  derived from different donors. Three biopsies reacted weakly. Unless 
stated otherwise, fluorescein  isotbioeyanate~conjugated goat anti-human IgG serum (Hyland 
Laboratories, Los Angeles, Calif.)  served for the second stage of the reaction. In all tests, cells 
were exposed  to this reagent alone for control. The results are expressed  as the fluorescence 
index (FI) which is calculated as follows: per cent negative ceils in the test sample minus the 
per cent negative cells in the control divided by the per cent negative ceils in the control. 
Since the controls often revealed very few or no positive cells, the results in these cases can be 
given also as per cent MIF-positive cells in the test sample. 
Anti-EBV Test.--Cells (about 34  X  105/cover slip) were sedimented at 900 g for 10 rain. 
The supemates were drained off and the cells resuspended in the remaining fluid. A small drop 
of suspension  was placed on a cover slip (6 X  30 ram), evenly spread, and rapidly dried at 
37°C. The preparations were then fixed in acetone at room temperature for 10 rain and stored 
in stoppered test tubes at --20°C until shipped from Stockholm to Philadelphia under dry ice 
refrigeration. 
The procedures for staining by the direct and indirect immunofluorescence techniques have 
been  described  (3).  Fluorescein  isothiocyanate-conjugated  human  T-globulin  served  for 
direct staining. For the indirect technique human sera with, as well as without, antibodies to 
EBV were used and goat anti-human IgG conjugates purchased from Hyland Laboratories. KLEIN  ET AL.  1013 
These conjugates which elicited detectable fluorescence when diluted  160-fold, were used in 
dilutions of 1:20 or 1:30. The percentages of immunofluorescent ceils were determined in at 
least 10 high power fields (750 X) in various areas of the smear and the average was calcu- 
late& 
RESULTS 
Various established  blastoid  cell lines of Burkitt  tumor or leukemic origins 
hadbeen testedformembraneimmunofluorescence and EBV antigens separately 
T~LEI 
~mpa~son~EBV-Posit#eC~sa~Membranelmmu~fl~r~c~ceinVariousCdlL~g 
Cell line 
Jijoye* 
EB3 (14) 
B35M (15) 
EB1 (14) 
SL1 (16) 
EB2 (14) 
Kudi* 
Ogun* 
Raji (17) 
SKL1 (18) 
SKL2 (18) 
SKL3 (18) 
SKIA (18) 
SKL5 (18) 
SKL7 (18) 
LK1D (19) 
RPMI 7466 (20) 
Origin 
Burkitt's lymphoma 
¢c  ¢, 
¢~  ~c 
Leukemia 
cc 
~c 
~c 
cg 
cl 
c¢ 
Healthy donor 
EBV-posifive ceils 
(Philadelphia lines) 
% 
5-15 
3-5 
2-3 
1-3 
1-2 
0.5-2 
0.3-1 
0.1-0.2 
0 
0.1-0.2 
<0.1 
0 
0 
0 
0 
0 
Membrane 
immunofluorescence  (PI) 
(Stockholm  lines) 
0.48 
0.29 
0.52 
n.t. 
0.37 
n.t. 
0.0 
0.03 
0.07 
0.0 
0.01 
0.03 
0.0 
0.02 
0.01 
0.02 
0 
* Pulvertaff, J. V. Unpublished observations. 
in the Stockholm and Philadelphia laboratories, respectively. While the results 
obtained with these cell lines (Table I) may not be strictly comparable,  since 
the lines had been maintained in different laboratories under partially different 
conditions, they nevertheless appeared to indicate that (a) cultures with <0.5 % 
EBV antigen-containing cells as a  rule do not yield significant MIF; (b) with 
rise  in  EBV-positive  cells  from 0.5  to up  to  15%,  the  percentages  of MIF- 
positive  cells  in  the  corresponding lines  increase  strikingly;  and  (c)  approxi- 
mately 10 times more cells show MIF than EBV antigen.  Only the Kudi cells 
do not  seem  to fit  this  pattern.  It is  possible  that  the  percentages  of EBV- 1014  EB  VIRAL  AND  CELL  MEMBRANE  IMMUNOFLUORESCENCE.  I 
positive cells in  the  Stockholm cultures were lower than in the Philadelphia 
line. These comparisons suggested that MIF depends not only on the presence 
of EBV but also upon the extent of the persistent viral infection. In order to 
confirm this suggestion,  strictly comparative tests were carried out. 
Recent studies in the Stockholm laboratory had been concentrated upon the 
establishment  of new  cell lines from Burkitt  tumor biopsies  (11)  and  their 
MIF reactivities. From cell suspensions used for the MIF tests,  a  few cover 
slip smears were made which, after acetone fixation, were sent to Philadelphia 
for determination of EBV antigen-containing cells. All fixed preparations were 
stained with  human "y-globulin  conjugates and  the specificity of the fluores- 
cence elicited in given lines was ascertained by the indirect method using sera 
known  to possess  antibodies  to  EBV  and  others  devoid of such  antibodies. 
Lately sera were used for this purpose which were taken from individuals prior 
to onset of infectious mononucleosis (IM) and again during the acute stage of 
this  disease  since  recent observations  indicate  that  EBV  is  one,  if not  the 
major cause of IM (21, 22). In every culture which revealed EBV-positive cells 
by the direct staining methods, indirect tests with  EBV-negative or pre-IM 
sera failed to yield positive results whereas with acute stage sera fluorescence 
was  clearly demonstrable, proving the presence of EBV. 
Fig.  1 summarizes results  obtained during three different periods in  MIF 
and EBV tests with several recently established Burkitt tumor lines. The data 
represent the average percentages of positive cells in given lines based upon 
from 2 to > 20 individual MIF tests and from 2-18 EBV tests. The lines were 
arranged  in  each  observation period  according  to  their  descending  order  of 
MIF  reactivities.  It is seen  that,  with  a  decrease in  MIF-positive cells,  the 
EBV-positive  cells  also  tended  to  decline but  there  was  no  constant  ratio 
between the percentages of positive cells as obtained by the two tests. Indeed, 
in some instances, high percentages of MIF-positive cells were noted but only 
relatively low percentages of EBV-positive cells, and conversely, some cultures 
revealed little MIF but relatively high levels of EBV antigen-containing cells. 
Furthermore, the order of the cell lines was found to vary from month to month 
to some extent. This was due in part to addition of new cell lines with high 
MIF reactivities, and in part also to changes in the reactivities of previously 
tested cultures.  Examples of such variations in  given cultures are  shown  in 
Fig. 2. The Silfere (A) and Esther (see Fig.  1) lines revealed strong MIF and 
unchanging  EBV  reactions  throughout  the  6-month  period  of  observation. 
The Annah (B) and Opasa cultures showed a gradual decline of EBV-positive 
cells which  was  accompanied  to  some  extent by a  decline also  of the  MIF 
activity.  Newly  established  cultures  of  Wilkister  (C)  or  Daudi  or  Katana 
revealed significant degrees of MIF from the beginning, that is when sufficient 
cells  became  first  available  for  test,  whereas  EBV-positive  cells  were  rare 
initially  but  reached  relatively  high  levels  on  further  maintenance  of  the KLEIN  ET  AL.  1015 
cultures.  In  another  newly  established  line  (Kiliopa,  D),  MIF  and  EBV 
reactions  appeared  gradually  and  apparently  in  paranel.  The  cultures  of 
Margaret  (E)  and Ekesa indicate that a  relatively high percentage of EBV- 
positive  cells  may not necessarily be  accompanied by significant degrees  of 
MIF  activity. The  Margaret  line developed  significant MIF  activity (70% 
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FIG. 1. Comparison of cell membrane and EBV-specific  immunofluorescence  in recently 
established cultures of Burkitt tumor cells. 
positive cells) after the present experiments were terminated. Finally, cultures 
of Dalmas (F), Issac, and Hamisi contained only few EBV and MIF-positive 
cells  in  the  course  of  these  studies. 
The  observation  that early cultures may show strong MIF reactions but 
may reveal few EBV-positive cells is matched by experience with fresh biopsy 
cell  suspensions.  It  was  shown  earlier  (2)  that many biopsies  yielded  cells 
suitable  for  MIF  tests.  In  contrast,  acetone-fixed  smears  of  cells  from  35 
biopsies revealed EBV-positive cells in only four  instances and then no more 
than 3-5  cells among tens of thousands present per slide.  In a few additional 
biopsies,  questionably positive structures were seen which resembled  disinte- 1016  EB  VIRAL AND  CELLMEMBRANE  IMMUNOFLUORESCENCE.  I 
grating  cells.  The  scarcity  of  positive  cells  and  their  irregular  presence  in 
different smears prevented specific identification of the  immunofluorescence as 
being due to EBV. Table II presents data on biopsy cells on which both MIF 
and EBV tests were carried out. 
The  results  described  indicated  that  different  antigens  and  antibodies 
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FIO.  2.  Patterns of changes in cell membrane and EBV-speciflc immunofluorescence in the 
course of maintenance of recently established cultures of Burkitt tumor cells. 
participate in the two types of immunofluorescence tests. This became evident 
also from two preliminary experiments in which the standard Mutua serum was 
adsorbed  with  MIF-positive cells  of  several lines.  As  a  consequence of  this 
procedure, the serum induced now only insignificant MIF reactions in appro- 
priate test cultures whereas the titer of antibodies to EBV was not affected. 
DISCUSSION 
The various  observations suggest  that  in  cultures  of  Burldtt  tumor  cells, 
whether  of  long  standing  or  recently initiated,  the  detection  of  membrane 
fluorescence may depend not only upon the presence of EB virus but to a con- 
siderable degree also upon the extent of the persistent EBV infection. Generally, KT.ELN"  ET  AL.  1017 
many more cells showed membrane fluorescence than EBV antigen  but there 
was no constant ratio between the percentages of cells which were reactive in 
the  two  tests.  Furthermore,  the  two  reactivities  in  given  cultures  did  not 
remain necessarily at constant levels as time progressed but showed increases 
or decreases,  often apparently independent  of each other.  Nevertheless,  when 
more than 0.5 %  of the cells in well-established  cultures revealed the presence 
of  EBV  antigen,  the  percentages  of  cells  with  membrane  fluorescence  were 
TABLE II 
Comparison of MIF and EBV Reactions of Cells  from Fresh Burkitt Tumor Biopsies 
Patient 
Kimone 
Ekesa 
Malakwe 
Wilkister 
Juma 
Opasa 
Fanis 
~ge 
8 
8 
5 
10 
I 
i 
3ex 
M 
M 
M 
F 
M 
M 
F 
KCC  Date of 
No.  biopsy 
813  11/14/67 
816  11/14/67 
2/21/68 
820  11/21/68 
819  12/6/67 
827  1/13/68 
1/26/68 
2/21/68 
766  1/13/68 
300  1/19/68 
MIF  reaction 
Reagent*  FI 
0.48 
0 
0.14 
0.10 
0.71 
0.39 
0.67 
0.54 
0.38 
0.33, 0.48 
0.45 
0.27 
0.55 
0.39 
0.42 
EBV  reaction 
Result  No. of  +  or (?) 
cells/smear 
--  0 
--  0 
?  (1) 
--  0 
+  1-2 
?  (2) 
?  (5) 
+  3-4 
-  0 
+  2-3 
* a  =  goat anti-human  kappa chain conjugate  (Hyland Laboratories),  b  =  rabbit anti- 
human IgG (G. Goldstein), c =  goat anti-human  3" globulin (Baltimore Biological Labora- 
tories, Baltimore, Md.), d =  goat anti-human IgG (Hyland Laboratories). 
usually  high  and,  conversely,  when  the  EBV-positive  cells  were  of very low 
frequency,  membrane  immunofluorescence  was,  as  a  rule,  negligible.  There 
were,  however,  a  number  of exceptions.  Young cultures,  and  especially  sus- 
pensions of fresh biopsy cells may yield high degrees of MIF in the presence of 
few or no EBV-positive cells. Conversely, older cultures may occasionally show 
relatively  large  numbers  of  EBV  antigen-producing  cells  in  the  absence  of 
significant MIF activity.  These observations imply that at least  two  distinct 
antigens are involved in the two types of tests. This is further supported by the 
fact, to be reported in a subsequent paper of this series, that sera can be found 
which  are highly reactive  in  the  MIF  test  but  show only low  titers  against 
EBV and vice versa. 1018  EB  VIRAL  AND  CELL  MEMBRANE  IM~UI~OFLUORESCENCE.  I 
The fact that fresh biopsy cells or young cultures may show significant NIIF 
activity but few or no EBV-positive cells might have two reasons: (a) Burkitt 
tumor patients generally have high levels of antibodies to EBV (3, 7, 21)  and 
some antibodies are likely to be carried over into the cultures. These antibodies 
may restrict  the  spread  of  the  infection until diluted  out in  the  course  of 
maintenance of the cultures and, since the virus-producing cells usually show 
varying degrees of degeneration, it is conceivable,  in addition, that antibody 
enters  and blocks  the EBV-staining reactions.  Antibodies to  cell  membrane 
antigens are also present in most patients' sera but the antigenic mass in tumors 
may exceed the capacity of available antibodies to block all surface antigen. 
However, 7-globulins have been detected on biopsy cells (23) and their presence 
could conceivably account for negative MIF tests with some of the biopsy cell 
suspension.  (b)  MIF-positive cells  generally exceed  EBV-positive cells  by a 
substantial factor.  If the virus  were responsible for inducing the membrane 
antigens, many more cells must be invaded by the virus than actually synthe- 
size viral capsid antigens. Some support for "nonproductive" cellular infections 
may be derived from the effect of arginine-deficient media upon the persistent 
EBV infection in Burkitt tumor cell cultures (6).  Such media prevent cellular 
divisions but  enhance  the  percentage  of  EBV  antigen-producing cells  by a 
factor of about 10. This observation has been interpreted to denote that the 
arginine  deficiency removed an intracellular block of viral  replication while 
enough arginine remains available within the cells for production of EB viral 
coat proteins. It is almost certain that arginine is required for this purpose as 
it is for synthesis of capsid proteins of other members of the herpes group (24- 
26).  The  assumption,  that  only about  1  in  10  invaded cells  supports  EBV 
replication, could account for the difference in the percentages of EBV- and 
MIF-positive cells ff one postulates that the viral genome in the other 9 cells 
is not entirely dormant but induces cellular surface changes which are reflected 
in  the membrane  immunofluorescence reaction. 
The reverse finding, that some cultures reveal relatively high levels of EBV- 
positive cells but no significant MIF activity is less readily explained. It has 
been noted, however, that the presence and concentration of membrane antigens 
depends to some extent upon the age of the cultures after the last feeding and 
whether or not certain antibiotics (kanamycin) are present in the culture media 
(unpublished observations). Proteins are apparently shed from the cell surface 
under certain conditions which could account for loss  of MIF activity. This 
possibility remains to be explored. 
SIYM~4RY 
A comparison was made of the immunofluorescence tests for detection of cell 
membrane and Epstein-Barr virus antigens in cells from Burkitt tumor biopsies 
or continuous cultures derived therefrom. On the whole, cell membrane fluores- KLEIN  ET  AL.  1019 
cence in  established lines appeared to depend not only upon  the presence of 
EBV but to a  considerable degree also upon the extent of the persistent viral 
infection. There was no constant relationship, however, between the results of 
the two tests and exceptions to the rule were noted. These observations indicate 
that different antigens are involved in the two tests. Biopsy cells in general and 
young cultures may reveal strong MIF activity but few, if any, EBV-positive 
cells.  The reverse,  the presence of relatively large numbers  of EBV antigen- 
containing cells in the absence of significant MIF reactions, was also noted on 
occasion in  a  few established  cultures.  The possible interpretations  of  these 
findings have been discussed. 
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